Press Releases Items Per Page 102550 News Category FinancialGeneral Year None20192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting Apr 04, 2017 Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for the Treatment of Immune and Inflammatory Disorders Mar 27, 2017 NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain Mar 20, 2017 Nektar to Webcast Presentation at Cowen and Company's 37th Annual Health Care Conference in Boston Mar 02, 2017 Nektar Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting Mar 01, 2017 Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results Mar 01, 2017 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2016 on Wednesday, March 1, 2017, After Close of U.S.-Based Financial Markets Feb 22, 2017 Clinical Data from Phase 1 Dose-Escalation Study of Single-Agent NKTR-214 in Patients with Renal Cell Carcinoma Presented at the ASCO 2017 Genitourinary Cancers Symposium Feb 18, 2017 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 05, 2017 Nektar Therapeutics to Present at Jefferies 2016 Global Healthcare Conference in London Nov 14, 2016 Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »